Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of the Oral Anticoagulant LY517717 Difumarate to Subcutaneous Enoxaparin for the Prevention of Venous Thromboembolic Events (VTE) Post-Total Hip Replacement (THR) and Post-Total Knee Replacement (TKR) Surgery

NCT00074828 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00074828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00074828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of the Oral Anticoagulant LY517717 Difumarate to Subcutaneous Enoxaparin for the Prevention of Venous Thromboembolic Events (VTE) Post-Total Hip Replacement (THR) and Post-Total Knee Replacement (TKR) Surgery
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
May 31, 2005
Enrollment
511 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

total hip replacement, total knee replacement